The Motley Fool Discussion Boards

Previous Page

Stocks N / Nabi Biopharmaceuticals


Subject:  Competition for NicVax? Date:  1/12/2006  6:06 PM
Author:  TheArch Number:  281 of 291

I'm not sure that I had heard or read about this here before. This is from Pfizer's 3rd quarter? report:

he Phase III development program is complete for varenicline, an innovative treatment for smoking cessation. Data are being prepared for global registrations and will be presented at November's American Heart Association meeting. Earlier data showed that varenicline represented an advance over existing prescription smoking-cessation treatments. In two Phase II trials evaluating the efficacy, safety, and tolerability of different doses of varenicline in healthy smokers, about half the